| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/17/2002 | CA2415422A1 Chromosome 3p21.3 genes are tumor suppressors |
| 01/17/2002 | CA2415350A1 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 01/17/2002 | CA2415179A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 01/17/2002 | CA2415127A1 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | CA2414495A1 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/17/2002 | CA2414460A1 Fimh adhesin proteins and methods of use |
| 01/17/2002 | CA2414374A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | CA2414272A1 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 01/17/2002 | CA2414219A1 Lipid metabolism molecules |
| 01/17/2002 | CA2413045A1 Expression system |
| 01/17/2002 | CA2412162A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | CA2412150A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/17/2002 | CA2412124A1 Connective tissue growth factor-2 |
| 01/17/2002 | CA2385142A1 New class of bioactive glycoprotein |
| 01/17/2002 | CA2351110A1 Helicobacter felis vaccine |
| 01/16/2002 | EP1172441A1 A promoter derived from phytosulfokine precursor gene |
| 01/16/2002 | EP1172377A1 Compounds and methods for inhibiting amyloid Beta-protein filament formation and neurotoxicity |
| 01/16/2002 | EP1172376A1 Peptide analogues at position 91 of human myelin basic protein for treatment of multiple sclerosis |
| 01/16/2002 | EP1172375A1 Gene expression, genome alteration and reporter gene expression in myofibroblasts and myofibroblasts-like cells by using the regulatory regions within the alpha smooth muscle alpha-actin gene |
| 01/16/2002 | EP1172374A1 Crystal structure (3 A resolution) of the 30S ribosome and its use |
| 01/16/2002 | EP1172372A1 Process for producing subunit peptide origintaing in polymer protein |
| 01/16/2002 | EP1172114A2 Stable concentrated insulin preparations for pulmonary delivery |
| 01/16/2002 | EP1171629A1 Novel essential bacterial genes and their proteins |
| 01/16/2002 | EP1171628A2 Compound screening methods |
| 01/16/2002 | EP1171626A1 50 human secreted proteins |
| 01/16/2002 | EP1171623A2 Production of attenuated negative stranded rna virus vaccines |
| 01/16/2002 | EP1171620A1 Acquired resistance genes in plants |
| 01/16/2002 | EP1171607A1 Streptokinase fragments and their use for inhibiting cell death |
| 01/16/2002 | EP1171606A2 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 01/16/2002 | EP1171605A1 Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof |
| 01/16/2002 | EP1171604A2 Dna sequence and recombinant production of a graminae allergen |
| 01/16/2002 | EP1171603A1 A process for producing purified biologically active, free form of recombinant human interferon gamma |
| 01/16/2002 | EP1171601A2 Nucleic acids encoding a mutt domain-containing polypeptide |
| 01/16/2002 | EP1171600A2 Zalpha13: a human secreted protein |
| 01/16/2002 | EP1171599A1 Adipocyte complement related protein homolog zacrp2 |
| 01/16/2002 | EP1171597A2 Prostate-restricted gene 30p3c8 expressed in prostate cancer |
| 01/16/2002 | EP1171596A1 Synthetic transmembrane components |
| 01/16/2002 | EP1171595A1 13 transmembrane protein expressed in prostate cancer |
| 01/16/2002 | EP1171594A1 Vascular endothelial cell growth factor variants and uses thereof |
| 01/16/2002 | EP1171593A2 Transmembrane (7tm) receptor r35 |
| 01/16/2002 | EP1171592A1 A method of altering the properties of a membrane-associated protein by substitution of the transmembrane domain |
| 01/16/2002 | EP1171591A1 48 human secreted proteins |
| 01/16/2002 | EP1171590A1 50 human secreted proteins |
| 01/16/2002 | EP1171589A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
| 01/16/2002 | EP1171588A1 P element derived vector and methods for its use |
| 01/16/2002 | EP1171587A1 Peptide from antigen muc-1 for triggering an immune response to tumor cells |
| 01/16/2002 | EP1171585A1 49 human secreted proteins |
| 01/16/2002 | EP1171582A2 Long lasting anti-angiogenic peptides |
| 01/16/2002 | EP1171580A2 Human homologues of fused gene |
| 01/16/2002 | EP1171579A1 Human tumor necrosis factor receptor tr9 |
| 01/16/2002 | EP1171577A2 Anti-bacterial vaccine compositions |
| 01/16/2002 | EP1171467A1 Axor-27, a g-protein coupled receptor |
| 01/16/2002 | EP1171466A2 G-protein coupled receptor and method of using same |
| 01/16/2002 | EP1171465A2 Analogs of gastric inhibitory peptide and their use for treatment of diabetes |
| 01/16/2002 | EP1171464A2 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
| 01/16/2002 | EP1171463A2 Peptide homodimers and peptide heterodimers, derived from interferon alpha 2 |
| 01/16/2002 | EP1171462A2 49 human secreted proteins |
| 01/16/2002 | EP1171461A2 Diagnostic marker for the human heart |
| 01/16/2002 | EP1171460A1 48 human secreted proteins |
| 01/16/2002 | EP1171459A1 Angiopoietin-like proteins, crisp proteins and polynucleotides encoding same |
| 01/16/2002 | EP1171458A1 50 human secreted proteins |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171456A1 50 human secreted proteins |
| 01/16/2002 | EP1171455A1 Polypeptide-k obtained from momordica charantia and a process for the extraction thereof |
| 01/16/2002 | EP1171454A1 Chimeric lyssavirus nucleic acids and polypeptides |
| 01/16/2002 | EP1171451A1 Separation of plasma components |
| 01/16/2002 | EP1171163A1 Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders |
| 01/16/2002 | EP1171153A2 Novel medical use of alpha-1-acidic glycoprotein (aag) or orosomucoid |
| 01/16/2002 | EP1171152A1 vMIP-II PEPTIDE ANTAGONISTS OF CXCR4 |
| 01/16/2002 | EP1171151A1 Thrombospondin-2 and uses thereof |
| 01/16/2002 | EP1171147A1 Modulation of excitable tissue function by peripherally administered erythropoietin |
| 01/16/2002 | EP1171143A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 01/16/2002 | EP1170998A2 Transformed cells useful for the control of pests |
| 01/16/2002 | EP1170993A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1 |
| 01/16/2002 | EP1170992A1 PURIFIED AND ISOLATED $i(piwi) FAMILY GENES AND GENE PRODUCTS AND METHODS EMPLOYING SAME |
| 01/16/2002 | EP0998189A4 Carotenoid-associated proteins useful for high carotenoid accumulation and production in plants and other organisms |
| 01/16/2002 | EP0896585B1 Humanized anti-cd40 monoclonal antibodies and fragments capable of blocking b cell activation |
| 01/16/2002 | EP0871732A4 Method of treating sepsis |
| 01/16/2002 | EP0840791B1 Generation of immune responses to prostate-specific antigen (psa) |
| 01/16/2002 | EP0817859B1 Recombinant dna vectors for gene therapy |
| 01/16/2002 | EP0794960B1 An aglucone isoflavone enriched vegetable protein concentrate and process for producing |
| 01/16/2002 | EP0791358B1 Therapeutic agent for ophthalmic diseases |
| 01/16/2002 | EP0786088B1 Presentation of lipoarabinomannan antigens to t-cells by cd1 molecules |
| 01/16/2002 | EP0782580A4 Parallel selex |
| 01/16/2002 | EP0743986B1 Heterologous dimeric proteins produced in heterokaryons |
| 01/16/2002 | EP0742903B1 Piperidine analogs and conjugates of procainamide and napa |
| 01/16/2002 | EP0721467B1 Use of relaxin as an analgesic and palliative for intractable pain |
| 01/16/2002 | EP0672681B1 Novel antitumor peptide |
| 01/16/2002 | EP0603386B1 Parenteral immunization against rotavirus |
| 01/16/2002 | EP0515516B1 Methods for identifying heterofunctional fusion proteins |
| 01/16/2002 | EP0496875B1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 01/16/2002 | CN1331753A Essential genes from C albicans and method for screening antimycotic substances using said genes |
| 01/16/2002 | CN1331746A Regulatory sequences useful for gene expression in plant embryo tissue |
| 01/16/2002 | CN1331701A Modified peptides as therapeutic agents |
| 01/16/2002 | CN1331700A Generation of antibodies using polynucleotide vaccination in avian species |
| 01/16/2002 | CN1331699A Methods of identifying antigen gene sequences |
| 01/16/2002 | CN1331603A Tolerance to xenograft |
| 01/16/2002 | CN1331558A Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 01/16/2002 | CN1331415A Application of combined antigen for African lymphocytoma virus to test serum reactions of nasopharyngeal cancer patient before and after treatment |
| 01/16/2002 | CN1331340A Polypeptide-human topoisomerase 12.1 and polynucleotide for coding it |